Furthermore, by indirectly regulating the Bcl-2, Nrf2 inhibited the BAD protein expression through the PI3K-AKT signalling pathway, resulting in drug resistance in B-ALL cells. The gene discussed is BAD; the disease is acute lymphoblastic leukemia.